Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
An overview of combined D-2- and L-2-hydroxyglutaric aciduria: functional analysis of CIC variants.
|
29238895 |
2018 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
|
29031613 |
2018 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
A novel homozygous SLC25A1 mutation with impaired mitochondrial complex V: Possible phenotypic expansion.
|
29226520 |
2018 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
BEFREE |
We report here for the first time a patient who manifested combined D-2- and L-2-hydroxyglutaric aciduria as a result of a hemizygous mutation in SLC25A1 in combination with 22q11.2 deletion.
|
29265763 |
2018 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Severe Neonatal Presentation of Mitochondrial Citrate Carrier (SLC25A1) Deficiency.
|
27306203 |
2016 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Expanding the Clinical Spectrum of Mitochondrial Citrate Carrier (SLC25A1) Deficiency: Facial Dysmorphism in Siblings with Epileptic Encephalopathy and Combined D,L-2-Hydroxyglutaric Aciduria.
|
25614306 |
2015 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
Biomarker
|
disease |
BEFREE |
Our results identify defects in SLC25A1 as a cause of combined D-2- and L-2-hydroxyglutaric aciduria.
|
23561848 |
2013 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter.
|
23393310 |
2013 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GermlineCausalMutation
|
disease |
ORPHANET |
Our results identify defects in SLC25A1 as a cause of combined D-2- and L-2-hydroxyglutaric aciduria.
|
23561848 |
2013 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Agenesis of corpus callosum and optic nerve hypoplasia due to mutations in SLC25A1 encoding the mitochondrial citrate transporter.
|
23393310 |
2013 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
UNIPROT |
Our results identify defects in SLC25A1 as a cause of combined D-2- and L-2-hydroxyglutaric aciduria.
|
23561848 |
2013 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Our results identify defects in SLC25A1 as a cause of combined D-2- and L-2-hydroxyglutaric aciduria.
|
23561848 |
2013 |
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
Biomarker
|
disease |
HPO |
|
|
|
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
Biomarker
|
disease |
CTD_human |
|
|
|
Combined D-2- and L-2-hydroxyglutaric aciduria
|
0.720 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.
|
26870663 |
2019 |
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in the Mitochondrial Citrate Carrier SLC25A1 are Associated with Impaired Neuromuscular Transmission.
|
26870663 |
2019 |
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Pathogenic mutations of the human mitochondrial citrate carrier SLC25A1 lead to impaired citrate export required for lipid, dolichol, ubiquinone and sterol synthesis.
|
29031613 |
2018 |
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Schizophrenia
|
0.320 |
Biomarker
|
disease |
BEFREE |
We examined whether variation within six genes from the VCFS critical region at 22q11 (DGSC, Stk22A1, DGSI, Gscl, Slc25A1 and Znf74) confers susceptibility to schizophrenia.
|
12476324 |
2002 |
Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
The human mitochondrial citrate transporter gene (SLC20A3) maps to chromosome band 22q11 within a region implicated in DiGeorge syndrome, velo-cardio-facial syndrome and schizophrenia.
|
8682495 |
1996 |
Congenital Myasthenic Syndromes, Presynaptic
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Seizures
|
0.120 |
GeneticVariation
|
phenotype |
BEFREE |
SLC25A1 mutations are associated with combined D,L-2-hydroxyglutaric aciduria (DL- 2HGA; OMIM #615182), characterized by muscular hypotonia, severe neurodevelopmental dysfunction and intractable seizures.
|
29226520 |
2018 |